ARTICLE | Clinical News
MitoQ: Phase II started
February 12, 2007 8:00 AM UTC
The company began a placebo-controlled, New Zealand Phase II trial in 36 patients who have been unresponsive to, or unsuitable for treatment with pegylated interferon plus ribavirin. ...